{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:59:09Z","timestamp":1785463149679,"version":"3.56.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16068-1","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:33:47Z","timestamp":1780058027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated in vitro and bioinformatic analysis of autophagy\u2011related gene expression modulated by Fe\u2082O\u2083\/Au core\u2013shell nanoparticles in breast cancer cells"],"prefix":"10.1186","volume":"26","author":[{"given":"Milad","family":"Sheervalilou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Sargazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheida","family":"Shahraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7996-845X","authenticated-orcid":false,"given":"Roghayeh","family":"Sheervalilou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"6","key":"16068_CR1","first-page":"pe1922","volume":"15","author":"S Shirvalilou","year":"2023","unstructured":"Shirvalilou S, et al. The future opportunities and remaining challenges in the application of nanoparticle-mediated hyperthermia combined with chemo\u2010radiotherapy in cancer. Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol. 2023;15(6):pe1922.","journal-title":"Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol"},{"issue":"9","key":"16068_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12032-022-01713-z","volume":"39","author":"H Ghaznavi","year":"2022","unstructured":"Ghaznavi H, et al. Effects of folate-conjugated Fe2O3@ Au core\u2013shell nanoparticles on oxidative stress markers, DNA damage, and histopathological characteristics: evidence from in vitro and in vivo studies. Med Oncol. 2022;39(9):122.","journal-title":"Med Oncol"},{"issue":"11","key":"16068_CR3","doi-asserted-by":"publisher","first-page":"20028","DOI":"10.1002\/jcp.28599","volume":"234","author":"F Hadi","year":"2019","unstructured":"Hadi F, et al. Combinatorial effects of radiofrequency hyperthermia and radiotherapy in the presence of magneto-plasmonic nanoparticles on MCF\u20107 breast cancer cells. J Cell Physiol. 2019;234(11):20028\u201335.","journal-title":"J Cell Physiol"},{"issue":"7","key":"16068_CR4","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s10103-017-2267-x","volume":"32","author":"N Eyvazzadeh","year":"2017","unstructured":"Eyvazzadeh N, et al. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer. Lasers Med Sci. 2017;32(7):1469\u201377.","journal-title":"Lasers Med Sci"},{"issue":"11","key":"16068_CR5","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/s00432-016-2179-3","volume":"142","author":"H Samadian","year":"2016","unstructured":"Samadian H, et al. Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy. J Cancer Res Clin Oncol. 2016;142(11):2217\u201329.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"16068_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1124\/molpharm.121.000234","volume":"100","author":"H Ghaznavi","year":"2021","unstructured":"Ghaznavi H, et al. An updated review on implications of autophagy and apoptosis in tumorigenesis: possible alterations in autophagy through engineered nanomaterials and their importance in cancer therapy. Mol Pharmacol. 2021;100(2):119\u201343.","journal-title":"Mol Pharmacol"},{"issue":"5","key":"16068_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/scientificamerican0563-64","volume":"208","author":"C De Duve","year":"1963","unstructured":"De Duve C. The lysosome. Sci Am. 1963;208(5):64\u201373.","journal-title":"Sci Am"},{"key":"16068_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.copbio.2015.08.016","volume":"36","author":"L Popp","year":"2015","unstructured":"Popp L, Segatori L. Differential autophagic responses to nano-sized materials. Curr Opin Biotechnol. 2015;36:129\u201336.","journal-title":"Curr Opin Biotechnol"},{"key":"16068_CR9","doi-asserted-by":"crossref","unstructured":"Dixon SJ, et al. Ferroptosis: an iron\u2013dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","DOI":"10.1016\/j.cell.2012.03.042"},{"key":"16068_CR10","doi-asserted-by":"crossref","unstructured":"Hou W, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12(8):1425\u20138.","DOI":"10.1080\/15548627.2016.1187366"},{"key":"16068_CR11","doi-asserted-by":"crossref","unstructured":"Stockwell BR, et al. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273\u201385.","DOI":"10.1016\/j.cell.2017.09.021"},{"issue":"12","key":"16068_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/nrc2254","volume":"7","author":"R Mathew","year":"2007","unstructured":"Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer. 2007;7(12):961\u20137.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"16068_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","volume":"43","author":"C He","year":"2009","unstructured":"He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009;43(1):67\u201393.","journal-title":"Annu Rev Genet"},{"issue":"1","key":"16068_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12951-016-0174-0","volume":"14","author":"VR Lopes","year":"2016","unstructured":"Lopes VR, et al. Dose-dependent autophagic effect of titanium dioxide nanoparticles in human HaCaT cells at non-cytotoxic levels. J Nanobiotechnol. 2016;14(1):22.","journal-title":"J Nanobiotechnol"},{"key":"16068_CR15","doi-asserted-by":"crossref","unstructured":"Ichimura Y, Komatsu M. Selective degradation of p62 by autophagy. Seminars in immunopathology. Springer; 2010;32(4):431\u20136.","DOI":"10.1007\/s00281-010-0220-1"},{"issue":"6","key":"16068_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2005.07.002","volume":"122","author":"S Pattingre","year":"2005","unstructured":"Pattingre S, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005;122(6):927\u201339.","journal-title":"Cell"},{"key":"16068_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pdpdt.2018.08.003","volume":"24","author":"V Hosseini","year":"2018","unstructured":"Hosseini V, et al. Multimodal cancer cell therapy using Au@ Fe2O3 core\u2013shell nanoparticles in combination with photo-thermo-radiotherapy. Photodiagn Photodyn Ther. 2018;24:129\u201335.","journal-title":"Photodiagn Photodyn Ther"},{"issue":"sup1","key":"16068_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/21691401.2017.1420072","volume":"46","author":"M Mirrahimi","year":"2018","unstructured":"Mirrahimi M, et al. Selective heat generation in cancer cells using a combination of 808 nm laser irradiation and the folate-conjugated Fe2O3@ Au nanocomplex. Artif cells Nanomed Biotechnol. 2018;46(sup1):241\u201353.","journal-title":"Artif cells Nanomed Biotechnol"},{"key":"16068_CR19","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.biopha.2017.02.002","volume":"88","author":"R Sheervalilou","year":"2017","unstructured":"Sheervalilou R, et al. Using miR-10b, miR-1 and miR-30a expression profiles of bronchoalveolar lavage and sputum for early detection of non-small cell lung cancer. Biomed Pharmacother. 2017;88:1173\u201382.","journal-title":"Biomed Pharmacother"},{"issue":"31","key":"16068_CR20","doi-asserted-by":"publisher","first-page":"20192","DOI":"10.1021\/acsomega.1c01763","volume":"6","author":"L Kiamohammadi","year":"2021","unstructured":"Kiamohammadi L, et al. Physical and biological properties of 5-fluorouracil polymer-coated magnetite nanographene oxide as a new thermosensitizer for alternative magnetic hyperthermia and a magnetic resonance imaging contrast agent: In vitro and in vivo study. ACS omega. 2021;6(31):20192\u2013204.","journal-title":"ACS omega"},{"issue":"1","key":"16068_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12645-023-00187-6","volume":"14","author":"R Sheervalilou","year":"2023","unstructured":"Sheervalilou R, et al. Magnetohyperthermia-synergistic glioma cancer therapy enabled by magnetic graphene oxide nanoheaters: Promising nanostructure for in vitro and in vivo applications. Cancer Nanotechnol. 2023;14(1):44.","journal-title":"Cancer Nanotechnol"},{"issue":"1","key":"16068_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12645-023-00164-z","volume":"14","author":"S Shirvalilou","year":"2023","unstructured":"Shirvalilou S, et al. Targeted magnetochemotherapy modified by 5-Fu-loaded thermally on\/off switching nanoheaters for the eradication of CT26 murine colon cancer by inducing apoptotic and autophagic cell death. Cancer Nanotechnol. 2023;14(1):11.","journal-title":"Cancer Nanotechnol"},{"issue":"2","key":"16068_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3233\/JAD-230966","volume":"98","author":"S Kavoosi","year":"2024","unstructured":"Kavoosi S, Shahraki A, Sheervalilou R. Identification of microRNA-mRNA regulatory networks with therapeutic values in Alzheimer\u2019s disease by bioinformatics analysis. J Alzheimer\u2019s Disease. 2024;98(2):671\u201389.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1","key":"16068_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12010-022-04151-9","volume":"195","author":"B Pourgholamali","year":"2023","unstructured":"Pourgholamali B, et al. Bioinformatic analysis divulged novel prognostic circulating microRNAs and their potential target genes in breast cancer. Appl Biochem Biotechnol. 2023;195(1):283\u201397.","journal-title":"Appl Biochem Biotechnol"},{"key":"16068_CR25","doi-asserted-by":"publisher","unstructured":"Beygi HS, Shahraki A, Sheervalilou R. Identification of hub genes and signaling pathways as possible therapeutic targets in human glioblastoma: evidenced by bioinformatics analysis. Brain Res, 2025;1874:150137. https:\/\/doi.org\/10.1016\/j.brainres.2025.150137.","DOI":"10.1016\/j.brainres.2025.150137"},{"issue":"1","key":"16068_CR26","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s12672-025-03272-x","volume":"16","author":"M Sheervalilou","year":"2025","unstructured":"Sheervalilou M, Ghanei M, Arabfard M. Shared blood gene signature in lung adenocarcinoma and microbial lung infections: a bioinformatic analysis and in silico validation. Discover Oncol. 2025;16(1):1403.","journal-title":"Discover Oncol"},{"issue":"6","key":"16068_CR27","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1021\/es062347t","volume":"41","author":"J-S Chang","year":"2007","unstructured":"Chang J-S, et al. In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ Sci Technol. 2007;41(6):2064\u20138.","journal-title":"Environ Sci Technol"},{"issue":"8","key":"16068_CR28","first-page":"1594","volume":"46","author":"H Ghaznavi","year":"2018","unstructured":"Ghaznavi H, et al. Folic acid conjugated PEG coated gold\u2013iron oxide core\u2013shell nanocomplex as a potential agent for targeted photothermal therapy of cancer. Artif Cells Nanomed Biotechnol. 2018;46(8):1594\u2013604.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"5","key":"16068_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2174\/1570180820666230228103903","volume":"21","author":"R Dinc","year":"2024","unstructured":"Dinc R. Magnetic nanoparticles with aspects of their use in cancer therapy. Lett Drug Des Discovery. 2024;21(5):847\u201357.","journal-title":"Lett Drug Des Discovery"},{"issue":"1","key":"16068_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/1570180820666230407110243","volume":"21","author":"D Joshi","year":"2024","unstructured":"Joshi D. An Insight into the role of biodegradable controlled-release polymers and nanoformulations for enhanced brain drug delivery. Lett Drug Des Discovery. 2024;21(1):62\u201370.","journal-title":"Lett Drug Des Discovery"},{"issue":"1","key":"16068_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40580-021-00260-z","volume":"8","author":"J Wen","year":"2021","unstructured":"Wen J, et al. Ultrasmall iron oxide nanoparticles induced ferroptosis via Beclin1\/ATG5-dependent autophagy pathway. Nano convergence. 2021;8(1):10.","journal-title":"Nano convergence"},{"issue":"12","key":"16068_CR32","doi-asserted-by":"publisher","first-page":"15457","DOI":"10.1021\/acsami.3c17418","volume":"16","author":"A Lewinska","year":"2024","unstructured":"Lewinska A, et al. Carbon-coated iron oxide nanoparticles promote reductive stress-mediated cytotoxic autophagy in drug-induced senescent breast cancer cells. ACS Appl Mater Interfaces. 2024;16(12):15457\u201378.","journal-title":"ACS Appl Mater Interfaces"},{"key":"16068_CR33","doi-asserted-by":"publisher","first-page":"723801","DOI":"10.3389\/fcell.2021.723801","volume":"9","author":"S Ma","year":"2021","unstructured":"Ma S, et al. Iron-dependent autophagic cell death induced by radiation in MDA-MB-231 breast cancer cells. Front cell Dev biology. 2021;9:723801.","journal-title":"Front cell Dev biology"},{"issue":"4","key":"16068_CR34","first-page":"57","volume":"20","author":"M Li","year":"2020","unstructured":"Li M, et al. Erastin triggers autophagic death of breast cancer cells by increasing intracellular iron levels. Oncol Lett. 2020;20(4):57.","journal-title":"Oncol Lett"},{"key":"16068_CR35","doi-asserted-by":"publisher","unstructured":"Guo C, et al. Amorphous silica nanoparticles trigger vascular endothelial cell injury through apoptosis and autophagy via reactive oxygen species-mediated MAPK\/Bcl-2 and PI3K\/Akt\/mTOR signaling. Int J Nanomed, 2016: p. 5257\u201376. https:\/\/doi.org\/10.2147\/IJN.S112030.","DOI":"10.2147\/IJN.S112030"},{"issue":"1","key":"16068_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/15548627.2018.1509171","volume":"15","author":"R Mohammadinejad","year":"2019","unstructured":"Mohammadinejad R, et al. Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles. Autophagy. 2019;15(1):4\u201333.","journal-title":"Autophagy"},{"key":"16068_CR37","unstructured":"Song X, ea. BECN1 governs the initiation of ferroptosis via system Xc\u207b regulation. Cell Death Differ. 2021;28:1073\u201385."},{"issue":"1","key":"16068_CR38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11033-025-10573-5","volume":"52","author":"A Bandyopadhyay","year":"2025","unstructured":"Bandyopadhyay A, et al. Autophagy mediated immune response regulation and drug resistance in cancer. Mol Biol Rep. 2025;52(1):492.","journal-title":"Mol Biol Rep"},{"key":"16068_CR39","doi-asserted-by":"publisher","first-page":"1412781","DOI":"10.3389\/fimmu.2024.1412781","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, et al. A comprehensive landscape analysis of autophagy in cancer development and drug resistance. Front Immunol. 2024;15:1412781.","journal-title":"Front Immunol"},{"issue":"8","key":"16068_CR40","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24(8):560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"16068_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27\u201342.","journal-title":"Cell"},{"issue":"3","key":"16068_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ebiom.2015.01.008","volume":"2","author":"H Tang","year":"2015","unstructured":"Tang H, et al. Decreased BECN1 mRNA expression in human breast cancer is associated with estrogen receptor-negative subtypes and poor prognosis. EBioMedicine. 2015;2(3):255\u201363.","journal-title":"EBioMedicine"},{"issue":"4","key":"16068_CR43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.molcel.2009.01.020","volume":"33","author":"V Kirkin","year":"2009","unstructured":"Kirkin V, et al. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell. 2009;33(4):505\u201316.","journal-title":"Mol Cell"},{"issue":"10","key":"16068_CR44","doi-asserted-by":"publisher","first-page":"e110293","DOI":"10.1371\/journal.pone.0110293","volume":"9","author":"J Ge","year":"2014","unstructured":"Ge J, et al. Upregulation of autophagy-related gene-5 (ATG-5) is associated with chemoresistance in human gastric cancer. PLoS ONE. 2014;9(10):e110293.","journal-title":"PLoS ONE"},{"issue":"1","key":"16068_CR45","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12885-022-09468-6","volume":"22","author":"E Philipson","year":"2022","unstructured":"Philipson E, et al. High expression of p62\/SQSTM1 predicts shorter survival for patients with pancreatic cancer. BMC Cancer. 2022;22(1):347.","journal-title":"BMC Cancer"},{"issue":"2","key":"16068_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2(2):127\u201337.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"16068_CR47","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15(12):786\u2013801.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"16068_CR48","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ccr.2014.02.025","volume":"25","author":"CL Arteaga","year":"2014","unstructured":"Arteaga CL, Engelman JA. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell. 2014;25(3):282\u2013303.","journal-title":"Cancer Cell"},{"issue":"4","key":"16068_CR49","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","volume":"79","author":"C-H Heldin","year":"1999","unstructured":"Heldin C-H, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79(4):1283\u2013316.","journal-title":"Physiol Rev"},{"issue":"5","key":"16068_CR50","doi-asserted-by":"publisher","first-page":"101042831769503","DOI":"10.1177\/1010428317695032","volume":"39","author":"R Sheervalilou","year":"2017","unstructured":"Sheervalilou R, et al. A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer. Tumor Biology. 2017;39(5):1010428317695032.","journal-title":"Tumor Biology"},{"issue":"6801","key":"16068_CR51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249\u201357.","journal-title":"Nature"},{"issue":"9","key":"16068_CR52","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"16068_CR53","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers JG, et al. Cardiac fibrosis: the fibroblast awakens. Circul Res. 2016;118(6):1021\u201340.","journal-title":"Circul Res"},{"issue":"32","key":"16068_CR54","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","volume":"37","author":"E Pur\u00e9","year":"2018","unstructured":"Pur\u00e9 E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018;37(32):4343\u201357.","journal-title":"Oncogene"},{"issue":"2","key":"16068_CR55","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathology: J Pathological Soc Great Br Irel. 2008;214(2):199\u2013210.","journal-title":"J Pathology: J Pathological Soc Great Br Irel"},{"issue":"3","key":"16068_CR56","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"16068_CR57","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110(6):673\u201387.","journal-title":"Cell"},{"issue":"15","key":"16068_CR58","first-page":"2747","volume":"128","author":"A Echarri","year":"2015","unstructured":"Echarri A, Del Pozo MA. Caveolae\u2013mechanosensitive membrane invaginations linked to actin filaments. J Cell Sci. 2015;128(15):2747\u201358.","journal-title":"J Cell Sci"},{"issue":"5","key":"16068_CR59","doi-asserted-by":"publisher","first-page":"a005033","DOI":"10.1101\/cshperspect.a005033","volume":"3","author":"B Geiger","year":"2011","unstructured":"Geiger B, Yamada KM. Molecular architecture and function of matrix adhesions. Cold Spring Harb Perspect Biol. 2011;3(5):a005033.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"43","key":"16068_CR60","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"16068_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14(1):7.","journal-title":"BMC Bioinformatics"},{"issue":"34","key":"16068_CR62","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741\u201351.","journal-title":"Oncogene"},{"issue":"1","key":"16068_CR63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP\u2013dependent transporters. Nat Rev Cancer. 2002;2(1):48\u201358.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"16068_CR64","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, et al. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13(10):714\u201326.","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"16068_CR65","doi-asserted-by":"publisher","first-page":"14672","DOI":"10.3390\/ijms232314672","volume":"23","author":"D Jurkovicova","year":"2022","unstructured":"Jurkovicova D, et al. DNA damage response in cancer therapy and resistance: challenges and opportunities. Int J Mol Sci. 2022;23(23):14672.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"16068_CR66","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s12276-022-00863-4","volume":"54","author":"Y Abuetabh","year":"2022","unstructured":"Abuetabh Y, et al. DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities. Exp Mol Med. 2022;54(10):1658\u201369.","journal-title":"Exp Mol Med"},{"issue":"2","key":"16068_CR67","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"16068_CR68","doi-asserted-by":"publisher","first-page":"a000141","DOI":"10.1101\/cshperspect.a000141","volume":"1","author":"M Karin","year":"2009","unstructured":"Karin M. NF-\u03baB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol. 2009;1(5):a000141.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"11","key":"16068_CR69","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9(11):798\u2013809.","journal-title":"Nat Rev Cancer"},{"issue":"5930","key":"16068_CR70","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029\u201333.","journal-title":"Science"},{"issue":"3","key":"16068_CR71","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"GL Semenza","year":"2012","unstructured":"Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148(3):399\u2013408.","journal-title":"Cell"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16068-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:23:30Z","timestamp":1785461010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16068-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16068"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16068-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the ethics committee of Zahedan University of Medical Sciences (Ethic code: IR.ZAUMS.REC.1399.437). The Ethical approval certificate is available at\n                      \n                      .","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"911"}}